ICH updates: E14 consultation, Health Canada implements M9 guideline

The International Council for Harmonisation (ICH) on Thursday announced its E14/S7B draft questions and answers guideline on clinical and nonclinical evaluation of QT/QTc interval and proarrhythmic potential has reached Step 2b of the ICH process.
 
On Friday, the European Medicines Agency (EMA) opened a three-month public consultation to gather feedback on the document. ICH will also be hosting a two-day public meeting to provide a high-level overview of the document in October.
 
EMA also released a report from its meeting in June to gather input from patients, healthcare professionals and researchers to inform an upcoming review to ICH’s good clinical practice (GCP) guideline, ICH E6(R3).
 
Earlier this week, Health Canada announced it has implemented both ICH M9: Biopharmaceutics Classification System (BCS)-Based Biowaivers, which provides a harmonized approach to biopharmaceutics classification of drugs and provides recommendations for when bioequivalence studies can be waived, and its accompanying questions and answers document.
 
Health Canada explains that the M9 guideline replaces its previous national-level guidance on BCS-based biowaivers and instructs drugmakers to complete its BCS-based biowaiver evaluation template for any submissions that include a biowaiver request.
 
Earlier this month, ICH released an introductory training presentation for the recent ICH S11 guideline and an updated user guide for ICH E2B(R3). (RELATED: ICH adopts S11 guideline on nonclinical safety testing for pediatric drugs, Regulatory Focus 14 April 2020; Health Canada adopts ICH pediatric drug development guidance, Regulatory Focus 20 August 2020).

Comments

Post a Comment

Popular posts from this blog

Understanding Quantitative, Qualitative, and Limit Tests in Pharmaceutical Quality Control

In pharmaceuticals, quantitative, qualitative, and limit tests refer to different approaches for analyzing drugs and their components: 1 . Quantitative Test: This determines the exact amount or concentration of a specific substance in a pharmaceutical product. It provides precise measurements, such as the amount of active pharmaceutical ingredient (API) or impurities present. For example, assays like High-Performance Liquid Chromatography (HPLC) are used to quantify substances. 2. Qualitative Test: This identifies the presence or absence of a particular substance but does not measure its amount. These tests confirm the identity of the compound, ensuring that the correct API is present. Techniques such as Infrared (IR) spectroscopy or Thin Layer Chromatography (TLC) can be used for qualitative analysis. 3. Limit Test: This is a type of semi-quantitative test used to check whether the concentration of a substance (like impurities) in a sample is within prescribed limits. It doesn’t prov...
Read more

USFDA Inspection Types

The FDA and States assisting the FDA under contract or cooperative agreements, in general, perform three types of inspections: surveillance, compliance follow up, and for-cause. Surveillance inspections are conducted to assess a facility’s or farm’s compliance with a regulation or to focus on an emerging trend in food safety. Surveillance inspections fall into two categories, routine and targeted. Routine inspections of facilities and farms are conducted to assess regulatory compliance. The FDA Food Safety Modernization Act mandates an inspection frequency of at least once every three years for domestic high-risk facilities and at least once every five years for non-high-risk facilities. In addition, the Food and Drug Omnibus Reform Act of 2022 mandated annual inspections of infant formula manufacturers in accordance with a risk-based approach. If necessary, inspections can be conducted more frequently. The FDA seeks to achieve comparable coverage of imported foods using an array of re...
Read more

Handling of Market Complaints and Their Importance in the Pharmaceutical Industry

In the pharmaceutical industry, market complaints serve as a critical feedback mechanism that helps maintain the safety, quality, and efficacy of products. Efficient handling of these complaints not only protects patient health but also strengthens the company's reputation and regulatory compliance. This blog post is to explore the importance of market complaints and best practices for managing them effectively. The Importance of Market Complaints Ensuring Patient Safety The primary objective of pharmaceutical companies is to provide safe and effective products to patients. Market complaints, especially those related to adverse drug reactions or product defects, can indicate potential risks. Immediate investigation and corrective action help prevent further harm to patients. Maintaining Product Quality Market complaints can reveal issues with the product’s quality, such as impurities, packaging defects, or labeling errors. Addressing these complaints promptly ensures that quality i...
Read more